Boston University

Running trials

• Not yet recruiting

  Creating Mobility-supported Home Play Environments to Enhance Development in Infants With Down Syndrome

  NCT07936396· Boston University Charles River Campus· Source

• Not yet recruiting

  Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance

  NCT07898592· Boston University Charles River Campus· Source

• Recruiting

  Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients

  NCT07455760· Boston University Charles River Campus· Source

• Active, not recruiting

  Telehealth Exercise and Mindfulness for Pain in Osteoarthritis - Stage 1B

  NCT06684587· Boston University Charles River Campus· Source

• Recruiting

  Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa

  NCT05624931· Boston University Charles River Campus· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819878· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  Positive Minds Strong Joints for Knee Osteoarthritis

  NCT06493903· Boston University Charles River Campus· Source

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06589986· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Harness-based Mobility Intervention for Infants With Down Syndrome

  NCT06219863· Boston University Charles River Campus· Source

• Recruiting

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  NCT06128629· Phase 3· Intellia Therapeutics· Source

• Enrolling by invitation

  Alzheimer's Plasma Extension

  NCT06416072· University of Southern California· Source

• Enrolling by invitation

  Alzheimer's Disease Neuroimaging Initiative 4

  NCT05617014· University of Southern California· Source

• Recruiting

  Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

  NCT05734313· Albert Einstein College of Medicine· Source

• Active, not recruiting

  Telehealth for Pain and Unhealthy Drinking Among PLWH

  NCT05503173· Boston University· Source

• Enrolling by invitation

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· Phase 3· Ionis Pharmaceuticals, Inc.· Source

• Recruiting

  Neural Mechanisms of Spatial Representations Beyond the Self

  NCT05406349· Boston University Charles River Campus· Source

• Active, not recruiting

  Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

  NCT05270668· Phase 2· Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)· Source

• Recruiting

  Improving Spatial Perception and Speech Understanding in Multitalker Mixtures

  NCT05260307· Boston University Charles River Campus· Source

• Active, not recruiting

  A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

  NCT05071300· Phase 3· Ionis Pharmaceuticals, Inc.· Source

• Active, not recruiting

  EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

  NCT04921787· Gavin Bart· Source

• Active, not recruiting

  Study in Parkinson Disease of Exercise

  NCT04284436· Northwestern University· Source

• Active, not recruiting

  A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

  NCT04961567· Phase 3· Biogen· Source

• Active, not recruiting

  Metformin in Alzheimer's Dementia Prevention

  NCT04098666· Phase 2/3· Columbia University· Source

• Active, not recruiting

  AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

  NCT04468659· Phase 3· Eisai Inc.· Source

• Recruiting

  PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  NCT04477785· Michael J. Fox Foundation for Parkinson's Research· Source

• Active, not recruiting

  Alpha-1 Antitrypsin Deficiency Adult Liver Study

  NCT02014415· St. Louis University· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Down syndrome3 recruiting
• Alzheimer disease2 recruiting
• Amyloidosis2 recruiting
• Parkinson disease2 recruiting
• Autism1 recruiting
• Crohn's disease1 recruiting
• Epilepsy1 recruiting
• Essential tremor1 recruiting
• Frontotemporal dementia1 recruiting
• Hearing loss1 recruiting
• HIV1 recruiting
• Type 1 diabetes1 recruiting

Closed trials

• Completed

  Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

  NCT06182241· Boston University Charles River Campus· Source

• Completed

  A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population

  NCT07174869· Indivi AG· Source

• Completed

  Sensor-based Just-in Time Adaptive Interventions (JITAIs) Targeting Eating Behavior

  NCT06547320· Phase 2· The Miriam Hospital· Source

• Completed

  The Benefits of Nature for Mood and Cognition in Persons With and Without Parkinson's Disease

  NCT06483126· Boston University Charles River Campus· Source

• Completed

  Predicting Language and Literacy Growth in Children With ASD Using Statistical Learning

  NCT06332144· Northeastern University· Source

• Completed

  Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

  NCT06234488· Medical College of Wisconsin· Source

• Completed

  Development of a Family-Based Transition Planning Program for Culturally-Diverse Youth on the Autism Spectrum

  NCT05965648· Boston University Charles River Campus· Source

• Completed

  Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures

  NCT05993832· Boston University Charles River Campus· Source

• Completed

  Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech

  NCT05437159· Boston University Charles River Campus· Source

• Completed

  Perception in Parkinson's Disease

  NCT05483036· Boston University Charles River Campus· Source

• Completed

  Zambia Infant Cohort Study - Brains Optimized for Surviving and Thriving

  NCT05119959· Boston University· Source

• Completed

  Neuroimaging Sleep and Mood in Depression

  NCT05497414· Boston University Charles River Campus· Source

• Completed

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· NYU Langone Health· Source

• Completed

  EXHIT ENTRE Comparative Effectiveness Trial

  NCT04345718· Phase 2/3· Gavin Bart· Source

• Completed

  A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)

  NCT04813926· Bayer· Source

• Completed

  Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial

  NCT04146428· University of California, Los Angeles· Source

• Completed

  Couples Lived Experience

  NCT04863495· NYU Langone Health· Source

• Completed

  Internet-based Video-conferencing to Address Alcohol Use and Pain: a Pilot Trial

  NCT04441593· Boston University Charles River Campus· Source

• Completed

  A Cluster Randomized Trial of the H2GO! Program

  NCT04265794· Boston University· Source

• Completed

  Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)

  NCT04295538· Phase 2· AbbVie· Source

• Completed

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· Phase 3· Ionis Pharmaceuticals, Inc.· Source

• Completed

  Trial of Parkinson's And Zoledronic Acid

  NCT03924414· Phase 4· California Pacific Medical Center Research Institute· Source

• Recruiting

  Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

  NCT03004326· Peter Merkel· Source

• Completed

  Alzheimer's Disease Neuroimaging Initiative 3

  NCT02854033· University of Southern California· Source

• Recruiting

  VCRC Tissue Repository

  NCT02967068· University of Pennsylvania· Source

• Completed

  Scleroderma Treatment With Autologous Transplant (STAT) Study

  NCT01413100· Phase 2· Fred Hutchinson Cancer Center· Source

• Completed

  Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

  NCT01064440· Phase 2· Helixmith Co., Ltd.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Alzheimer disease414 works · 7 trials
• Stroke303 works · 0 trials
• HIV275 works · 4 trials
• Obesity149 works · 2 trials
• Heart failure144 works · 0 trials
• Osteoarthritis132 works · 2 trials
• Tuberculosis123 works · 0 trials
• Type 2 diabetes83 works · 0 trials
• Chronic kidney disease66 works · 0 trials
• Atrial fibrillation62 works · 0 trials
• Amyloidosis59 works · 3 trials
• Parkinson disease58 works · 6 trials
• Asthma44 works · 0 trials
• Schizophrenia40 works · 0 trials
• Epilepsy37 works · 1 trial
• COPD32 works · 0 trials
• Coronary artery disease32 works · 0 trials
• Sickle cell disease30 works · 0 trials
• Autism28 works · 4 trials
• Cervical cancer21 works · 1 trial
• Down syndrome21 works · 3 trials
• Hearing loss19 works · 2 trials
• Idiopathic pulmonary fibrosis19 works · 0 trials
• Systemic sclerosis (scleroderma)18 works · 2 trials
• Insomnia16 works · 0 trials
• Peripheral artery disease14 works · 1 trial
• Hepatitis C13 works · 0 trials
• Head and neck cancer12 works · 0 trials
• Dystonia12 works · 0 trials
• Hypothyroidism11 works · 0 trials